<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
<journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
<journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
<journal-title-group>
<journal-title>JCI Insight</journal-title>
</journal-title-group>
<issn pub-type="epub">2379-3708</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30626759</article-id>
<article-id pub-id-type="pmc">6485671</article-id>
<article-id pub-id-type="publisher-id">122163</article-id>
<article-id pub-id-type="doi">10.1172/jci.insight.122163</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptome network analysis identifies protective role of the LXR/SREBP-1c axis in murine pulmonary fibrosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Shichino</surname>
<given-names>Shigeyuki</given-names>
</name>
<email>shichino@m.u-tokyo.ac.jp</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ueha</surname>
<given-names>Satoshi</given-names>
</name>
<email>ueha@m.u-tokyo.ac.jp</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hashimoto</surname>
<given-names>Shinichi</given-names>
</name>
<email>hashimot@m.u-tokyo.ac.jp</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Otsuji</surname>
<given-names>Mikiya</given-names>
</name>
<email>otsuji16@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7511-4502</contrib-id>
<name>
<surname>Abe</surname>
<given-names>Jun</given-names>
</name>
<email>j.abe1140@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3100-6934</contrib-id>
<name>
<surname>Tsukui</surname>
<given-names>Tatsuya</given-names>
</name>
<email>tsukutatsu@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deshimaru</surname>
<given-names>Shungo</given-names>
</name>
<email>deshimaru@rs.tus.ac.jp</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nakajima</surname>
<given-names>Takuya</given-names>
</name>
<email>t.nakajima0404@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kosugi-Kanaya</surname>
<given-names>Mizuha</given-names>
</name>
<email>eaudefeuille@gmail.com</email>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shand</surname>
<given-names>Francis H.W.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Inagaki</surname>
<given-names>Yutaka</given-names>
</name>
<email>yutakai@is.icc.u-tokai.ac.jp</email>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shimano</surname>
<given-names>Hitoshi</given-names>
</name>
<email>shimano-tky@umin.ac.jp</email>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Matsushima</surname>
<given-names>Kouji</given-names>
</name>
<email>koujim@m.u-tokyo.ac.jp</email>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.</aff>
<aff id="A2"><label>2</label>Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute of Biomedical Sciences, Tokyo University of Science, Chiba, Japan.</aff>
<aff id="A3"><label>3</label>Department of Integrative Medicine for Longevity, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan.</aff>
<aff id="A4"><label>4</label>Theodor Kocher Institute, University of Bern, Bern, Switzerland.</aff>
<aff id="A5"><label>5</label>Center for Matrix Biology and Medicine, Graduate School of Medicine, Tokai University, Kanagawa, Japan.</aff>
<aff id="A6"><label>6</label>Department of Endocrinology and Metabolism, Faculty of Medicine, University of Tsukuba, Chiba, Japan.</aff>
<author-notes>
<corresp>Address correspondence to: Kouji Matsushima, Division of Molecular Regulation of Inflammatory and Immune Diseases, Research Institute of Biomedical Sciences, Tokyo University of Science, Building 17 second floor, 2641, Yamasaki, Noda, Chiba 278-0042, Japan. Phone: 81.4.7121.4114; Email: <email>koujim@rs.tus.ac.jp</email>.</corresp>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest:</bold> The authors declare no conflicts of financial interest.</p>
</fn>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2019-01-10T09:00:00-0500" publication-format="electronic">
<day>10</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date date-type="collection" iso-8601-date="2019-01-10T09:00:00-0500" publication-format="electronic">
<day>10</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>1</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 0 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>4</volume>
<issue>1</issue>
<elocation-id>e122163</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2019, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://insight.jci.org/articles/view/122163">This article is available online at https://insight.jci.org/articles/view/122163</self-uri>
<abstract>
<p>Pulmonary fibrosis (PF) is an intractable disorder with a poor prognosis. Although lung fibroblasts play a central role in PF, the key regulatory molecules involved in this process remain unknown. To address this issue, we performed a time-course transcriptome analysis on lung fibroblasts of bleomycin- and silica-treated murine lungs. We found gene modules whose expression kinetics were associated with the progression of PF and human idiopathic PF (IPF). Upstream analysis of a transcriptome network helped in identifying 55 hub transcription factors that were highly connected with PF-associated gene modules. Of these hubs, the expression of <italic>Srebf1</italic> decreased in line with progression of PF and human IPF, suggesting its suppressive role in fibroblast activation. Consistently, adoptive transfer and genetic modification studies revealed that the hub transcription factor SREBP-1c suppressed PF-associated gene expression changes in lung fibroblasts and PF pathology in vivo. Moreover, therapeutic pharmacological activation of LXR, an SREBP-1c activator, suppressed the Srebf1-dependent activation of fibroblasts and progression of PF. Thus, SREBP-1c acts as a protective hub of lung fibroblast activation in PF. Collectively, the findings of the current study may prove to be valuable in the development of effective therapeutic strategies for PF.</p>
</abstract>
<abstract abstract-type="toc">
<p>Time-course transcriptome network analysis of lung fibroblasts reveals the LXR-SREBP-1c axis as a protective hub of fibroblast activation in murine pulmonary fibrosis.</p>
</abstract>
<kwd-group kwd-group-type="specialties">
<kwd>Inflammation</kwd>
<kwd>Pulmonology</kwd>
</kwd-group>
<kwd-group kwd-group-type="keywords">
<kwd>Bioinformatics</kwd>
<kwd>Fibrosis</kwd>
<kwd>Mouse models</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research on Innovative Areas program</funding-source>
<award-id>17H06392</award-id>
</award-group>
<award-group>
<funding-source>the Japan Society for the Promotion of Science Grant-in-Aid for Challenging Research(Exploratory)</funding-source>
<award-id>17K19546</award-id>
</award-group>
<award-group>
<funding-source>the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (B)</funding-source>
<award-id>16H05203</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>